Date: 28th September | Location: Boston MA
Come learn how you can accelerate your early stage clinical programs in the UK at a breakfast Friday 28th September 2018 in Boston.
Please join Richmond Pharmacology and the UK’s Department for International Trade to learn about innovative early drug development opportunities in the UK. The discussion will focus on how the UK’s pragmatic regulations, pioneering study design and seamless clinical trials approvals across Europe can help drive your early stage clinical programs and maximize data.
Guests will also hear the latest developments in the UK government’s Brexit negotiations and the likely impact of Brexit on the regulatory environment as well as the UK life sciences sector more broadly.
Full schedule to follow, please email firstname.lastname@example.org confirm interest in attending.
“I am very pleased with the Project Management of both studies undertaken on behalf of (blank) and any future studies we have to outsource will automatically be contracted to you.”
“Many thanks for your time today, most impressed with the quality of the follow up to our enquiry.”
“Please know that it has been an absolute pleasure collaborating with you and that I am most appreciative of the key contributions RPL has made to this project thus far. I hope I have the opportunity to work with RPL again in the very near future.”
Richmond Pharmacology is constantly assessing health and safety risks posed by COVID-19 and is regularly reviewingRead more ›
Richmond Pharmacology update on SARS-CoV-2 infection control and management of clinical trialsRead more ›